An author’s perspective: Montserrat Carrasco-Triguero on immunogenicity of antibody–drug conjugates

To give us an expert insight into the paper recently published in Bioanalysis: Immunogenicity of antibody–drug conjugates: observations across 8 molecules in 11 clinical trials, author Montserrat Carrasco-Triguero (Genentech, CA, USA) answers some of our questions; discussing her inspiration and the next steps for her research.  I am a Senior Scientist at Genentech (CA, USA) where I manage a group that develops and runs immunoassays to assess product pharmacokinetics, host immune response and biomarkers of product effect such as activity and safety. Previously, I held positions at Genitope (CA, USA) and Chiron (CA, USA). I earned my Ph.D. in Pharmacy...

To view this content, please register now for access

It's completely free